Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FDX vs GSK✓SelectedUSD · GSKFDX vs GSK performance historyLatest closeAs of+1.52%11/13
Stock and ETF performance explorer

FDX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.2%
GSK return
+44.4%
Excess return
+31.8%
Maximum drawdown
-45.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.5%+0.5%+1.0%+1.4%
7D+5.2%+1.1%+4.1%+5.0%
30D+11.3%+6.3%+4.9%+10.1%
3M-4.1%+1.8%-5.9%-4.5%
6M+9.6%+1.7%+8.0%+9.1%
YTD+40.9%+6.5%+34.4%+39.5%
1Y+53.0%+9.5%+43.5%+50.9%
3Y+74.1%+65.3%+8.8%+59.9%
All+76.2%+44.4%+31.8%+57.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling